Pretreatment with intravenous amiodarone improves the efficacy of ibutilide treatment on cardioversion rate and maintenance time of sinus rhythm in patients with persistent atrial fibrillation

  • Authors:
    • Zengxiang Dong
    • Hong Yao
    • Zhuangzhuang Miao
    • Hao Wang
    • Rongsheng Xie
    • Ye Wang
    • Yingfang Shang
    • Chunlin Gong
    • Zhaoguang Liang
  • View Affiliations

  • Published online on: April 20, 2017     https://doi.org/10.3892/br.2017.896
0

Abstract

The aim of the present study was to assess the efficacy and safety of the pharmacological conversion of persistent atrial fibrillation (AF) using amiodarone or/and ibutilide. Seventy‑nine consecutive patients (48 males and 31 females; mean age, 64.6±11.2 years; range, 40‑80 years) with non‑valvular chronic AF lasting >7 days (range, 7‑97 days) that were admitted to hospital for elective pharmacological cardioversion were randomly assigned to receive treatment with intravenous ibutilide (1 mg plus an additional 1 mg if required; n=39) or intravenous amiodarone (300 mg) plus intravenous ibutilide (1 mg; n=40). Success rates of cardioversion were 51.3% (20/39 patients) for ibutilide alone and 71.8% (28/39 patients) for amiodarone + ibutilide (P<0.05). A comparable increase in the QTc interval was observed in the two groups. It was observed that the co‑administration of amiodarone and ibutilide was safer than ibutilide alone with regard to the risk of ventricular arrhythmia. Forty‑eight patients of successful cardioversion were personally contacted for follow‑up. The result indicated that the sinus rhythm maintenance time of the amiodarone + ibutilide group (4.36±2.44 months) was significantly higher than that of the ibutilide group (2.34±1.75 months; P<0.01). In conclusion, pretreatment with intravenous amiodarone + ibutilide for pharmacological cardioversion of persistent AF is considered to be more effective and safer than treatment with ibutilide alone.

Related Articles

Journal Cover

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Dong, Z., Yao, H., Miao, Z., Wang, H., Xie, R., Wang, Y. ... Liang, Z. (1899). Pretreatment with intravenous amiodarone improves the efficacy of ibutilide treatment on cardioversion rate and maintenance time of sinus rhythm in patients with persistent atrial fibrillation. Biomedical Reports, 0, 0-0. https://doi.org/10.3892/br.2017.896
MLA
Dong, Z., Yao, H., Miao, Z., Wang, H., Xie, R., Wang, Y., Shang, Y., Gong, C., Liang, Z."Pretreatment with intravenous amiodarone improves the efficacy of ibutilide treatment on cardioversion rate and maintenance time of sinus rhythm in patients with persistent atrial fibrillation". Biomedical Reports 0.0 (1899): 0-0.
Chicago
Dong, Z., Yao, H., Miao, Z., Wang, H., Xie, R., Wang, Y., Shang, Y., Gong, C., Liang, Z."Pretreatment with intravenous amiodarone improves the efficacy of ibutilide treatment on cardioversion rate and maintenance time of sinus rhythm in patients with persistent atrial fibrillation". Biomedical Reports 0, no. 0 (1899): 0-0. https://doi.org/10.3892/br.2017.896